Table 2.
Scores | TA (n = 38) | LA (n = 39) | ||||
---|---|---|---|---|---|---|
Pre-treatment | Post-treatment | Follow up | Pre-treatment | Post-treatment | Follow up | |
NIH-CPSI (total) | 26.7 ± 4.9 | 22.6 ± 5.2* | 17.3 ± 9.1* | 26.6 ± 5.8 | 17.0 ± 6.0*△ | 9.4 ± 8.6*△ |
Pain or discomfort | 11.1 ± 2.8 | 9.0 ± 2.7* | 6.6 ± 4.0* | 11.1 ± 3.1 | 6.5 ± 3.0*△ | 3.3 ± 3.8*△ |
Urination | 5.8 ± 2.8 | 5.0 ± 2.0* | 3.8 ± 3.1* | 5.4 ± 3.3 | 3.5 ± 2.6*△ | 2.1 ± 2.6* |
Impact of symptoms | 5.0 ± 1.0 | 4.4 ± 1.2* | 3.4 ± 1.8* | 5.2 ± 1.1 | 3.5 ± 1.6*△ | 2.0 ± 1.7*△ |
Quality of life | 4.9 ± 1.2 | 4.4 ± 1.4* | 3.5 ± 1.7* | 4.9 ± 1.1 | 3.5 ± 1.3*△ | 2.0 ± 1.6*△ |
CM symptom | 15.3 ± 7.3 | 12.1 ± 5.7* | - | 14.0 ± 5.0 | 8.4 ± 5.3*△ | - |
*, P < 0.05 when comparison the pre-treatment score and post-treatment score in the same group; △, P < 0.05 when comparing the long-needle acupuncture group and the conventional acupuncture group. An ITT method was applied for analysis